Koyfin Home > Directory > Health Care > Replimune Group Inc > Cash and Short-Term Investments

Replimune Group Inc Cash and Short-Term Investments Chart (REPL)

Replimune Group Inc annual/quarterly Cash and Short-Term Investments from 2017 to 2020.
  • Replimune Group Inc Cash and Short-Term Investments for the quarter ending June 06, 2020 was $262m a 58.02% increase of 152m year over year
  • Replimune Group Inc Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $262m a 58.02% increase of 152m year over year
  • Replimune Group Inc Annual Cash and Short-Term Investments for 2020 was $169m a 20.02% increase of 34m from 2019
  • Replimune Group Inc Annual Cash and Short-Term Investments for 2019 was $135m a 54.34% increase of 73m from 2018
  • Replimune Group Inc Annual Cash and Short-Term Investments for 2018 was $62m a 66.54% increase of 41m from 2017
Other Balance Sheet Metrics:
  • Replimune Group Inc Total Assets for the quarter ending December 12, 2018 was $152m a 57.19% increase of 87m year over year
  • Replimune Group Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a 69.05% increase of 0m year over year
  • Replimune Group Inc Total Equity for the quarter ending December 12, 2018 was $143m a 58.16% increase of 83m year over year
View Chart On Koyfin

Quarterly REPL Cash and Short-Term Investments Data

06/2020$262m
03/2020$169m
12/2019$181m
09/2019$110m
06/2019$121m
03/2019$135m
12/2018$142m
09/2018$148m
06/2018$52m
03/2018$62m

Annual REPL Cash and Short-Term Investments Data

2020$169m
2019$135m
2018$62m
2017$21m